๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Reversible activation of non-steroid binding oestrogen receptor

โœ Scribed by Raymoure, William J.; McNaught, Reid W.; Smith, Roy G.

Book ID
109738869
Publisher
Nature Publishing Group
Year
1985
Tongue
English
Weight
346 KB
Volume
314
Category
Article
ISSN
0028-0836

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Non-competitive steroid inhibition of oe
Non-competitive steroid inhibition of oestrogen receptor functions
โœ John R. Puddefoot; Stewart Barker; Hilary R. Glover; Sylvanie D.M. Malouitre; Ga ๐Ÿ“‚ Article ๐Ÿ“… 2002 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 648 KB

Currently available antioestrogens, such as tamoxifen, are competitive inhibitors that bind to the ligand binding sites of oestrogen receptors, ERalpha and ERbeta. The search for alternative anti-hormone therapies is prompted by the need for drugs that are effective when tumours become tamoxifen res

Effect of ovarian steroid deficiency on
Effect of ovarian steroid deficiency on oestrogen receptor ? expression in bone
โœ Hoyland, Judith A.; Baris, Charlotte; Wood, Lindsay; Baird, Pauline; Selby, Pete ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 626 KB

The mechanism by which oestrogen and hormone replacement therapy (HRT) maintain bone mass in women is still unclear. It has previously been shown that cells of osteoblast lineage in vivo, particularly osteocytes, express oestrogen receptor (ER ). Nevertheless, it is still debatable whether oestrogen